Roger Strode Discusses Impact of Proposed Noncompete Clause Ban on Health Care Sector
11 January 2023
Foley & Lardner LLP Partner Roger Strode is quoted in the Healthcare Dive article, “Doctors no longer bound by noncompetes under FTC’s proposed ban,” discussing the potential impact on the health care sector of a rule put forward by the Federal Trade Commission (FTC) that would prohibit companies from requiring workers to sign noncompete clauses.
Strode explained that abolishing noncompetes may not be enforceable in nonprofit organizations, which are widespread in the health care sector. “The FTC may not have the authority under the FTC Act to impose this rule on nonprofit organizations,” he said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”